Knowledge
Sector Insight
The success or failure of large pharmaceutical companies is driven by the so-called blockbuster drugs that have annual sales of at least $1 billion and are used by tens of millions of patients.
However, blockbusters aren’t everything.
Specialty pharmaceuticals, Read More >>News
TriZetto agrees to be acquired by Apax Partners for $22 per share
The TriZetto Group, Inc. announced today that it has entered into a definitive agreement to be acquired and taken private by funds advised by Apax Partners.
Read More >>
Capio announces closing of purchase of Unilabs’ majority shareholders’ stake
Capio today announced that it has closed its purchase of the entire stake of registered and bearer shares and options of Unilabs from its majority shareholders.
Read More >>
Apax Partners Acquires Qualitest Pharmaceuticals and Vintage Pharmaceuticals
Funds advised by Apax Partners have agreed to acquire Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals based in Huntsville, Alabama, USA.
Read More >>